RecruitingNot ApplicableNCT05984797

Integrated Short-Term Palliative Rehabilitation in Incurable Cancer

Integrated Short-term Palliative Rehabilitation to Improve Quality of Life and Equitable Care Access in Incurable Cancer: A Multi-national Randomised Controlled Trial


Sponsor

King's College London

Enrollment

340 participants

Start Date

Apr 18, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this intervention trial is to determine if palliative rehabilitation in addition to usual care is more effective than usual care at improving health-related quality of life in patients with incurable solid cancer.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Aged 18 years or older.
  • Diagnosis of incurable solid cancer: lung, colorectal, breast, prostate or other, irrespective of timing in relation to any oncology or palliative care treatments
  • Eastern Cooperative Oncology Group performance status 2-3
  • Able to provide informed consent and complete trial assessments in available languages.

Exclusion Criteria3

  • Blood cancers: Leukaemia, Lymphoma, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorder (MPD), Multiple Myeloma.
  • Currently receiving specialist rehabilitation* for their cancer or co-morbidity-related dysfunction, or received within the two weeks prior to consent.
  • Clinician rated prognosis of less than 3 months.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERIntegrated Short-term Palliative Rehabilitation

Participants will be offered up to 3 manualised sessions (face to face and/or remotely, via telephone or video-conference) delivered by an expert rehabilitation practitioner (physiotherapist, occupational therapist,). Core components focus on (i) self-management of symptoms, (ii) physical activities and fitness, and (iii) social participation. Delivery of rehabilitation intervention components will include explicit use of behaviour change techniques including goal setting and action planning to focus on outcomes that are meaningful for the person, their family, and clinicians.


Locations(11)

Herlev Hospital

Herlev, Denmark

Hôpital Lyon Sud HCL

Lyon, France

Istituto Nazionale dei Tumori di Milano

Milan, Italy

AUSL di Reggio Emilia

Reggio Emilia, Italy

St Olav's Hospital

Trondheim, Norway

Western General Hospital in Edinburgh

Edinburgh, United Kingdom

St Gemma's Hospice

Leeds, United Kingdom

Guy's and St Thomas' NHS Foundation Trust

London, United Kingdom

King's College Hospital

London, United Kingdom

Worthing Hospital

Worthing, United Kingdom

York and Scarborough Teaching Hospitals NHS Foundation Trust

York, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05984797


Related Trials